<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Nucl Med</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Nucl Med</journal-id><journal-id journal-id-type="pmc-domain-id">1297</journal-id><journal-id journal-id-type="pmc-domain">ijnm</journal-id><journal-id journal-id-type="publisher-id">IJNM</journal-id><journal-id journal-id-type="publisher-id">Indian J Nucl Med</journal-id><journal-title-group><journal-title>Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India</journal-title></journal-title-group><issn pub-type="ppub">0972-3919</issn><issn pub-type="epub">0974-0244</issn><publisher><publisher-name>Wolters Kluwer -- Medknow Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11708788</article-id><article-id pub-id-type="pmcid-ver">PMC11708788.1</article-id><article-id pub-id-type="pmcaid">11708788</article-id><article-id pub-id-type="pmcaiid">11708788</article-id><article-id pub-id-type="pmid">39790816</article-id><article-id pub-id-type="doi">10.4103/ijnm.ijnm_2_24</article-id><article-id pub-id-type="publisher-id">IJNM-39-259</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>GFR Estimation and Correlation for Oncology Patients by Two Methods, Gates Method and Dual Time Point Plasma Sampling Method</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Tayal</surname><given-names initials="S">Sachin</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shukla</surname><given-names initials="V">Varun</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Venkatachalam</surname><given-names initials="M">Manikandan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kumar</surname><given-names initials="A">Ajay</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jha</surname><given-names initials="UN">Uddeshya Narayan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">
<italic toggle="yes">Department of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Varanasi, India</italic>
</aff><author-notes><corresp id="cor1"><italic toggle="yes"><bold>Address for correspondence:</bold> Mr. Sachin Tayal, Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi A Unit of Tata Memorial Centre, BHU Campus, Sunadar Bagiya, Varanasi - 221 005, Uttar Pradesh, India. E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sachintayal7@gmail.com">sachintayal7@gmail.com</email></italic></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2024</year></pub-date><volume>39</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">478996</issue-id><fpage>259</fpage><lpage>264</lpage><history><date date-type="received"><day>01</day><month>1</month><year>2024</year></date><date date-type="rev-recd"><day>29</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>03</day><month>5</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>09</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-10 09:26:30.110"><day>10</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; 2024 Indian Journal of Nuclear Medicine</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="IJNM-39-259.pdf"/><abstract><sec id="st1"><title>Background:</title><p>With the increasing number of oncology cases and a parallel surge in chemotherapeutic drugs for treatment, the treating physicians conducts nephrotoxicity evaluation to provide a personalized dosing strategy. Of the various tests available, glomerular filtration rate (GFR) under gamma camera with help of Gates method has gained importance, being a good index of overall kidney functions. In addition to this, there has been an alternate and old method for GFR estimation: plasma sampling. We at our Institution conducted both the methods for better evaluation of GFR in cancer patient management.</p></sec><sec id="st2"><title>Aim:</title><p>Comparison of Gates&#8217; camera based GFR based on kidney depth correction using Tonessen&#8217;s method and CT based manual depth calculation with dual time point plasma sampling in cancer patients.</p></sec><sec id="st3"><title>Method:</title><p>A retrospective study wherein patients&#8217; database were evaluated over a period of four months after approval from our Institutional Review Board. Thirty patients were included in the study. GFR was evaluated by two methods: Gates camera based and dual time plasma sampling method. Statistical analysis was done to help evaluate a correlation coefficient between the methods (Gates&#8217; method with and without CT based manual depth correction and dual time point plasma sampling).</p></sec><sec id="st4"><title>Results:</title><p>Our study showed moderate correlation between Gates&#8217; camera based GFR and dual time plasma sampling method.</p></sec><sec id="st5"><title>Conclusion:</title><p>One need to understand the limitation of each method and see if the renal depth corrections can be done with the help of CT or lateral images of NM for near accurate GFR and in case of selecting dual plasma sampling, errors to be minimized in pipetting and sample counting. Hence, it will be better to use both the methods for coming to a conclusion.</p></sec></abstract><kwd-group><kwd><italic toggle="yes">Glomerular filtration rate</italic></kwd><kwd><italic toggle="yes">kidney depth</italic></kwd><kwd><italic toggle="yes">plasma sampling</italic></kwd></kwd-group><funding-group><funding-statement>
Nil.
</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>With the increasing number of oncology cases per year, there has been a parallel surge in the usage of chemotherapeutic drugs too, for its treatment. To detect nephrotoxicity and provide a personalized dosing strategy, routine evaluation of kidney functioning is assessed by the treating physicians. There are in general, two pathways involved for excretion of the drug: glomerular filtration and tubular secretion. Tubular secretion can be performed but is laborious and of unclear clinical significance.[<xref rid="R1" ref-type="bibr">1</xref>] Hence, glomerular filtration rate (GFR) assessment is preferred. GFR is defined as a rate of filtration of fluids by the kidneys and a method for evaluating kidney function.[<xref rid="R2" ref-type="bibr">2</xref>] The gold standard method for GFR estimation, however, is through constant intravenous infusion of inulin and bladder catheterization.[<xref rid="R3" ref-type="bibr">3</xref>] Being an invasive process and difficult to perform, leads to its limited usage in clinical practice.[<xref rid="R4" ref-type="bibr">4</xref>] Second, the inulin process is time-consuming, expansive, and poorly available posing a challenge for routine usage. In addition to this method, 24 h endogenous creatinine clearance method can also be adopted but reliability is too dependent on accurate urine collection.[<xref rid="R5" ref-type="bibr">5</xref><xref rid="R6" ref-type="bibr">6</xref><xref rid="R7" ref-type="bibr">7</xref><xref rid="R8" ref-type="bibr">8</xref><xref rid="R9" ref-type="bibr">9</xref><xref rid="R10" ref-type="bibr">10</xref><xref rid="R11" ref-type="bibr">11</xref>] Of the various tests available, GFR under gamma camera with the help of the Gates&#8217; method has gained importance, as it gives a good index of overall kidney functions.[<xref rid="R12" ref-type="bibr">12</xref><xref rid="R13" ref-type="bibr">13</xref>] Second, it is one of the best measures of functioning kidney mass.[<xref rid="R1" ref-type="bibr">1</xref>] It was Gary Gates, who first evaluated GFR from radiopharmaceutical uptake study in the kidneys. Since then, GFR measurement with a camera-based method using <sup>99m</sup>Tc diethylenetriaminepentaacetate (DTPA) has been quite an economical and easy method for renal function evaluation.[<xref rid="R3" ref-type="bibr">3</xref><xref rid="R14" ref-type="bibr">14</xref>] Second, it can help determine unilateral renal blood flow, that too immediately. Another alternate and old method for GFR estimation was multisample technique, wherein multiple blood samples were collected (plasma method) after regular intervals postinjection of radiotracer for generating time activity curve to help evaluate GFR using Russel&#8217;s formula. With the passage of time and to achieve more functionality and making it less exhaustive, single plasma and double plasma methods were derived from multisample technique.[<xref rid="R2" ref-type="bibr">2</xref><xref rid="R15" ref-type="bibr">15</xref>] We at our institution carry out both methods (Gates&#8217; method and dual plasma sample method) for better evaluation of GFR in cancer patient management for coming chemotherapy cycle, especially in borderline cases (GFR &lt;65 mL/min).</p><sec><title>Aim</title><p>Comparison of Gates&#8217; camera-based GFR based on kidney depth correction using Tonessen&#8217;s method and computed tomography (CT)-based manual depth calculation with dual-time point plasma sampling in cancer patients.</p></sec></sec><sec sec-type="methods"><title>Methods</title><p>This is a retrospective study wherein patients&#8217; databases were evaluated from June 2022 to September 2022 at Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Varanasi. Thirty patients were included in the study as per the following inclusion:</p><list list-type="bullet"><list-item><p>Age 18 and above</p></list-item><list-item><p>Serum creatinine report of not more than 2 weeks from the date of study</p></list-item><list-item><p>Patient not pregnant</p></list-item><list-item><p>Having both dual-time plasma sampling and Gates&#8217; camera-based method data.</p></list-item></list><p>The study review process was approved by the Institutional Review Board of Mahamana Pandit Madan Moan Malaviya Cancer Centre, Varanasi (OIEC/11000694/2023/00001, dated November 2, 2023).</p><sec><title>Glomerular filtration rate measurement under gamma camera</title><p>The radiopharmaceutical, <sup>99m</sup>Tc-DTPA used in routine clinical practice for conducting the study under gamma camera was prepared in-house by using freshly eluted <sup>99m</sup>Tc supplied by SDS life sciences <sup>99</sup>Mo-<sup>99m</sup>Tc generator and cold kit of DTPA, procured from Board of Radiation and Isotope Technology, Mumbai, India. The acquisition of images was done as per the standard operating procedure guideline. Half an hour before the study, each patient was encouraged to drink at least 300 mL of water and each patient&#8217;s height, weight, age, and sex were recorded in the system. First, presyringe/full syringe count of <sup>99m</sup>Tc DTPA activity of 185MBq, measured with the help of calibrated dose calibrator-Capintec INC, CRC 25tW, used for the study was taken. It was followed by injecting intravenously the same radiopharmaceutical (which had a labeling yield of over 97%) as a bolus under a gamma camera. A total of 7-min dynamic study was acquired in a 64 &#215; 64 matrix in two phases using GE&#8217;s NMCT/670 dual head gamma camera with a low-energy high-resolution collimator (LEHR) and the patient positioned in a supine position with arms elevated over the head. First phase was 2 s per frame for 1-min duration followed by 15 s per frame for the rest of the time. This sequential imaging following the passage of radiotracer through the kidney constitutes the renogram. The syringe with the remaining activity used in the clinical study was counted as postinjection activity after renogram acquisition. The pre- and postsyringe counts under gamma camera were taken for 1 min each on a 128 &#215; 128 matrix, which helped in calculating the net activity injected in the body. For the processing of GFR study acquired under a gamma camera, regions of interest (ROI) were drawn around the kidney and a background at the inferior pole of the kidney avoiding any other tissue to obtain time activity curves. The background area was drawn since the kidney ROI contains the contribution from tissues over and underlying the kidney, which should be removed before the estimation of GFR [<xref rid="ijnm.ijnm_2_24-F1" ref-type="fig">Figure 1</xref>a]. Based on the 2&#8211;3-min period postinjection images, GFR was calculated. All necessary correction: background activity, linear attenuation, and kidney depth correction based on the height and weight of the patient using Tonnesen&#8217;s formula was applied as shown in <xref rid="ijnm.ijnm_2_24-T1" ref-type="table">Table 1</xref>.</p><fig position="float" id="ijnm.ijnm_2_24-F1" orientation="portrait"><label>Figure 1</label><caption><p>(a) Region of interest image around left and right kidney and its background region, (b) Computed tomography image used for depth evaluation for left and right kidney</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g001.jpg"/></fig><table-wrap position="float" id="ijnm.ijnm_2_24-T1" orientation="portrait"><label>Table 1</label><caption><p>Tonnesen&#8217;s formula and its parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="left" rowspan="1" colspan="1">Calculation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Right kidney depth (cm)</td><td align="left" rowspan="1" colspan="1">13.3 (weight/height) +0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Left kidney depth (cm)</td><td align="left" rowspan="1" colspan="1">13.2 (weight/height) +0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected counts of the right kidney</td><td align="left" rowspan="1" colspan="1">Right kidney counts-background/e-<sup>&#181; xR</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected counts of the left kidney</td><td align="left" rowspan="1" colspan="1">Left kidney counts-background/e-<sup>&#181; xL</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Height measured in cm, weight measured in kg. &#181;: Linear attenuation coefficient: 0.153/cm for <sup>99 m</sup>Tc, xR: Depth of right kidney, xL: Depth of left kidney</p></fn></table-wrap-foot></table-wrap><p>The accuracy of camera-based method is dependent on the estimated kidney depth as is evident in the above-mentioned equation. It was also calculated manually with the help of previous CT images available in the picture archiving and communication system of the institution. Axial views of the previously acquired CT images were chosen and renal depth was defined as the distance from the middle point of anteroposterior diameter to the body surface on the back in each view [<xref rid="ijnm.ijnm_2_24-F1" ref-type="fig">Figure 1</xref>b].</p></sec><sec><title>Plasma sampling method</title><p>A standard solution was prepared with the same amount of activity which was used for clinical study and a presyringe count was acquired for 1 min under gamma camera. After this, the activity was emptied in a conical flask, and postsyringe counts were acquired at the same time under the gamma camera. Venous blood samples (4 mL) were collected from the contralateral arm at 120 and 240-min postinjection time. Plasma counting was done under a calibrated well counter (Capintec INC, CRC 25tW) the next day after it was separated from the collected blood by separation through centrifuging at 3000 g for 15 min. About 1 mL of plasma from each sample was taken out with the help of pipette, taking care to avoid disturbing the interface between plasma and the red cells. An equal volume of standard was counted in a calibrated well counter with necessary background corrections. Counting of all the samples was done after selection of proper energy peak and window of <sup>99m</sup>Tc. Quality control was performed on all the equipment used in the study (dose calibrator and well counter). Finally, Russell&#8217;s formula, as shown in <xref rid="ijnm.ijnm_2_24-T2" ref-type="table">Table 2</xref>, was used for GFR estimation.</p><table-wrap position="float" id="ijnm.ijnm_2_24-T2" orientation="portrait"><label>Table 2</label><caption><p>Statistical analysis was done to help evaluate a correlation coefficient between the methods (Gates&#8217; method with and without computed tomography-based manual depth correction and dual-time point plasma sampling)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJNM-39-259-g002.jpg"/>
</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>D: Dose measured under gamma camera (preinjection counts), R: Residue dose after injection (postinjection counts), ADS: Activity of 1 mL dilution of standard in 1000 mL, DS: Dilution of standard (1000 mL), AS: Activity of standard sample measured under gamma camera, D: Administered activity (counts per min), P<sub>1</sub>: Activity at T<sub>1</sub> (counts/min/mL), P<sub>2</sub>: Activity at T<sub>2</sub> (counts/min/mL), T<sub>1</sub>=120 min, T<sub>2</sub>=240 min, GFR: Glomerular filtration rate</p></fn></table-wrap-foot></table-wrap><p>Statistical analysis was done to help evaluate a correlation coefficient between the methods (Gates&#8217; method with and without CT-based manual depth correction and dual-time point plasma sampling).</p></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 30 patients&#8217; data were analyzed, consisting of 20 (66.67%) males and 10 (33.33%) females. Among these, fifteen had carcinoma of the head-and-neck region, three with carcinoma of the cervix, two with carcinoma of esophageal, one with renal cell carcinoma, one with gallbladder carcinoma, one with carcinoma endometrium, one carcinoma anal canal, one carcinoma penis, one acute myeloid leukemia, one with metastasis of unknown origin, one myeloma, one urothelial carcinoma, and one with urinary bladder carcinoma. The mean age was 53.97 &#177; 10.79 years (range 33&#8211;73 years). The mean height was 159.2 &#177; 9.72 cm and the mean weight was 54.93 &#177; 12.44 kg. The mean GFR calculated by Gates&#8217; method and dual-time point plasma sampling method (DPSM) were 81.69 &#177; 24.76 and 66.15 &#177; 23.66, respectively. The representation of the demographics is shown in <xref rid="ijnm.ijnm_2_24-T3" ref-type="table">Table 3</xref>. GFR calculated by Gates&#8217; method and dual-time point plasma sampling are shown with the help of a scatter plot and regression line [<xref rid="ijnm.ijnm_2_24-F2" ref-type="fig">Figure 2</xref>]. Based on the above plots, the correlation coefficient of Gates&#8217; method GFR and plasma sampling GFR was 0.66, which can be interpreted as a moderate correlation and was statistically significant with a <italic toggle="yes">P</italic> &lt; 0.0001. The Bland&#8211;Altman plot [<xref rid="ijnm.ijnm_2_24-F3" ref-type="fig">Figure 3</xref>] showed good agreement between GFRs calculated by Gates&#8217; method and plasma sampling (<italic toggle="yes">P</italic> &lt; 0.0001) as most of the differences between GFR calculated by Gates&#8217; method and plasma sampling fall within &#177;1.95 standard deviation. The GFR calculated by dual-time point plasma sampling did not fall between &#177;10% of GFR calculated by Gates&#8217; method as shown in <xref rid="ijnm.ijnm_2_24-F4" ref-type="fig">Figure 4</xref> and the box-and-whiskers plot [<xref rid="ijnm.ijnm_2_24-F5" ref-type="fig">Figure 5</xref>] showed that the median GFR calculated by Gates&#8217; method was more than that of the GFR calculated by plasma sampling. However, when we compare GFR calculated by Gates&#8217; method and CT-based manual depth correction, it was found to have a high positive relationship [<italic toggle="yes">r</italic> = 0.85, <xref rid="ijnm.ijnm_2_24-F6" ref-type="fig">Figure 6</xref>a] but, there was a moderate positive relationship [<italic toggle="yes">r</italic> = 0.65, <xref rid="ijnm.ijnm_2_24-F6" ref-type="fig">Figure 6</xref>b] between dual-time point plasma sampling and GFR with CT-based manual depth correction. There is a statistically significant difference between GFR calculated by Gates&#8217; method and GFR with CT-based manually corrected depth method (<italic toggle="yes">P</italic> &lt; 0.0001) as well as between plasma sampling and GFR with CT-based manually corrected depth method (<italic toggle="yes">P</italic> &lt; 0.0001).</p><fig position="float" id="ijnm.ijnm_2_24-F2" orientation="portrait"><label>Figure 2</label><caption><p>Correlation between glomerular filtration rates calculated by Gates&#8217; method and plasma sampling (<italic toggle="yes">r</italic> = 0.66; y = 36.062 + 0.689x). GFR: Glomerular filtration rate</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g003.jpg"/></fig><fig position="float" id="ijnm.ijnm_2_24-F3" orientation="portrait"><label>Figure 3</label><caption><p>Bland&#8211;Altman plot for glomerular filtration rates calculated by Gates&#8217; method and plasma sampling (<italic toggle="yes">P</italic> &lt; 0.0001). GFR: Glomerular filtration rate</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g004.jpg"/></fig><fig position="float" id="ijnm.ijnm_2_24-F4" orientation="portrait"><label>Figure 4</label><caption><p>Line plot showing the glomerular filtration rate (GFR) calculated by plasma sampling whether lies within &#177;10% GFR calculated Gates&#8217; method. GFR: Glomerular filtration rate</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g005.jpg"/></fig><fig position="float" id="ijnm.ijnm_2_24-F5" orientation="portrait"><label>Figure 5</label><caption><p>Box-and-whiskers plot for comparing the glomerular filtration rates calculated by Gates&#8217; method and plasma sampling. GFR: Glomerular filtration rate</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g006.jpg"/></fig><fig position="float" id="ijnm.ijnm_2_24-F6" orientation="portrait"><label>Figure 6</label><caption><p>(a) Correlation between Gates&#8217; method glomerular filtration rate (GFR) and GFR-depth correction (<italic toggle="yes">r</italic> = 0.85; y = 20.745 + 0.969&#215;), (b) Correlation between plasma sampling and GFR-depth correction (<italic toggle="yes">r</italic> = 0.65; y = 48.362 + 0.779&#215;). GFR: Glomerular filtration rate</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJNM-39-259-g007.jpg"/></fig><table-wrap position="float" id="ijnm.ijnm_2_24-T3" orientation="portrait"><label>Table 3</label><caption><p>Clinical characteristics of 30 patients in the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Values</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">53.97&#177;10.79</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;&#160;Male</td><td align="center" rowspan="1" colspan="1">20 (66.67)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#160;&#160;&#160;Female</td><td align="center" rowspan="1" colspan="1">10 (33.33)</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">159.2&#177;9.72</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">54.93&#177;12.44</td></tr><tr><td align="left" rowspan="1" colspan="1">Gates&#8217; method GFR</td><td align="center" rowspan="1" colspan="1">81.69&#177;24.76</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma sampling GFR</td><td align="center" rowspan="1" colspan="1">66.15&#177;23.66</td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p>GFR: Glomerular filtration rate</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Accurate estimation of GFR helps the oncologist with more precise chemotherapeutic drug dosing. Therefore, it is imperative that the best possible method be chosen to calculate GFR. Indeed, Gates&#8217; method is one of the most convenient and faster processes.[<xref rid="R3" ref-type="bibr">3</xref><xref rid="R14" ref-type="bibr">14</xref>] It has the added advantage of providing differential function while others provide global function only. However, many factors such as renal depth,[<xref rid="R16" ref-type="bibr">16</xref>] extravasation, height, weight, and hydration status can affect the outcome. Second, <sup>99m</sup>Tc-DTPA is diffusible and rapidly enters the extravascular space after injection.[<xref rid="R17" ref-type="bibr">17</xref>] Hence, background corrections are a must before the final processing of GFR to avoid contribution from tissues over and underlying the kidney.[<xref rid="R18" ref-type="bibr">18</xref><xref rid="R19" ref-type="bibr">19</xref>] In addition to this, renal depth is also an important factor. It becomes more significant when working with LEHR collimators as the full-width half maximum varies considerably with the distance of the source to collimator as compared to low-energy all-purpose.[<xref rid="R17" ref-type="bibr">17</xref>] It has been clearly observed that the renal depth calculation is being underestimated in the Gates&#8217; method using Tonnessen&#8217;s formula and our results are in consensus to the previous study done by other authors.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr">22</xref>] Renal depth variation can cause GFR error.[<xref rid="R23" ref-type="bibr">23</xref><xref rid="R24" ref-type="bibr">24</xref>] Ma <italic toggle="yes">et al</italic>. showed in their study that a 1 cm error in kidney depth leads to an 18% difference in adult&#8217;s GFR.[<xref rid="R25" ref-type="bibr">25</xref>] Hence, in our study, we did the calculation of GFR with manually measured renal depth on the previously acquired CT image, which helps in giving a better and near-accurate GFR with correct values of renal depth application in the Gates&#8217; formula. An alternative to using CT images for depth correction can be acquiring a lateral view after completion of renal dynamic scan if feasible, which can reduce the radiation burden too.[<xref rid="R26" ref-type="bibr">26</xref>] On the other hand, plasma sampling stands out to be a better method for evaluation avoiding the above-mentioned limitation. However, this technique also has its own limitations: erroneous preparation of standard, incorrect sampling timing, error in pipetting, and unintentional extravascular injection of tracer.[<xref rid="R27" ref-type="bibr">27</xref>] Instead of multisample technique, the one adopted at our center of two-sample technique can be taken into consideration as has been shown by Kumar <italic toggle="yes">et al</italic>. in their study, wherein the two-sample method a derivation of the multisample method has shown to be of significant correlation. In another study on the Indian population by Hephzibah <italic toggle="yes">et al</italic>., a poor correlation[<xref rid="R27" ref-type="bibr">27</xref>] is seen between Gates&#8217; method and the single/double plasma sampling method. Our study, however, showed a moderate correlation and this could be due to the challenges of overcoming all possible errors in routine practice while performing this method.</p></sec><sec sec-type="conclusion"><title>Conclusion</title><p>In our study, a direct comparison of GFR values was done between the three methods (automated kidney depth Gates&#8217; method, manual depth correction in Gates&#8217; method, two sample plasma sampling). Although inulin clearance is considered a gold standard, in GFR measurement, this methodology is time-consuming, expensive, and not easily available. The endogenous markers, used for assessing GFR are not ideal and occasionally do not perform well. In a busy department like ours, it becomes a challenge collecting samples at an accurate time and it confines one person dedicated to the task for the entire procedure. One can completely agree that quantification of GFR is a challenging activity as there are innumerable variables with Gates and DPSM, leading to less correlation among each. Clinicians need to understand the limitations of each method and see if the renal depth corrections can be done with the help of CT or lateral images of Nuclear Medicine (NM) for near-accurate GFR and in the case of selecting dual plasma sampling, errors to be minimized in pipetting and sample counting. Hence, it will be better to use both methods for coming to a conclusion. Manual depth correction is better when working with LEHR. Accurate estimation of GFR shall help in more precise dosing of chemotherapeutic drugs as well as detection of early nephrotoxicity. The GFR values acceptable at our institute are &gt;65 mL/min/1.73 m<sup>2</sup>.</p><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Rosner</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>WK</given-names></name></person-group><article-title>Renal function testing</article-title><source>Am J Kidney Dis</source><year>2006</year><volume>47</volume><fpage>174</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16377400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.ajkd.2005.08.038</pub-id></element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>M</given-names></name><name name-style="western"><surname>Arora</surname><given-names>G</given-names></name><name name-style="western"><surname>Damle</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>M</given-names></name><name name-style="western"><surname>Bal</surname><given-names>C</given-names></name><etal/></person-group><article-title>Comparison between two-sample method with (99m) Tc-diethylenetriaminepentaacetic acid, Gates&#8217; method and estimated glomerular filtration rate values by formula based methods in healthy kidney donor population</article-title><source>Indian J Nucl Med</source><year>2017</year><volume>32</volume><fpage>188</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">28680201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/ijnm.IJNM_17_17</pub-id><pub-id pub-id-type="pmcid">PMC5482013</pub-id></element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>CD</given-names></name></person-group><article-title>Estimation of glomerular filtration rate using <sup>99m</sup>Tc-DTPA and the gamma camera</article-title><source>Eur J Nucl Med</source><year>1987</year><volume>12</volume><fpage>548</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">3552689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00296095</pub-id></element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>AM</given-names></name><name name-style="western"><surname>Glass</surname><given-names>DM</given-names></name><name name-style="western"><surname>Bird</surname><given-names>NJ</given-names></name></person-group><article-title>Extracellular fluid volume and glomerular filtration rate: Their relation and variabilities in patients with renal disease and healthy individuals</article-title><source>Nucl Med Commun</source><year>2011</year><volume>32</volume><fpage>649</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">21399552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MNM.0b013e3283457466</pub-id></element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Millward</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Webster</surname><given-names>LK</given-names></name><name name-style="western"><surname>Toner</surname><given-names>GC</given-names></name><name name-style="western"><surname>Bishop</surname><given-names>JF</given-names></name><name name-style="western"><surname>Rischin</surname><given-names>D</given-names></name><name name-style="western"><surname>Stokes</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Carboplatin dosing based on measurement of renal function-experience at the Peter MacCallum Cancer Institute</article-title><source>Aust N Z J Med</source><year>1996</year><volume>26</volume><fpage>372</fpage><lpage>9</lpage><comment>1</comment><pub-id pub-id-type="pmid">8811211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1445-5994.1996.tb01925.x</pub-id></element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Luke</surname><given-names>DR</given-names></name><name name-style="western"><surname>Halstenson</surname><given-names>CE</given-names></name><name name-style="western"><surname>Opsahl</surname><given-names>JA</given-names></name><name name-style="western"><surname>Matzke</surname><given-names>GR</given-names></name></person-group><article-title>Validity of creatinine clearance estimates in the assessment of renal function</article-title><source>Clin Pharmacol Ther</source><year>1990</year><volume>48</volume><fpage>503</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2225710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/clpt.1990.186</pub-id></element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Tsubaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Goodin</surname><given-names>S</given-names></name><name name-style="western"><surname>Leader</surname><given-names>WG</given-names></name><name name-style="western"><surname>Chandler</surname><given-names>MH</given-names></name></person-group><article-title>Estimation of creatinine clearance in patients with gynecologic cancer</article-title><source>Clin Pharm</source><year>1993</year><volume>12</volume><fpage>685</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">8306567</pub-id></element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>JT</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>SK</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>PE</given-names></name></person-group><article-title>Correlation between measured creatinine clearance and calculated creatinine clearance in ovarian cancer patients</article-title><source>Gynecol Oncol</source><year>1990</year><volume>36</volume><fpage>66</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2295454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0090-8258(90)90110-7</pub-id></element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>BA</given-names></name><name name-style="western"><surname>Frampton</surname><given-names>CM</given-names></name><name name-style="western"><surname>Colls</surname><given-names>BM</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>CH</given-names></name><name name-style="western"><surname>Fitzharris</surname><given-names>BM</given-names></name></person-group><article-title>Comparison of methods of assessment of renal function in patients with cancer treated with cisplatin, carboplatin or methotrexate</article-title><source>Aust N Z J Med</source><year>1990</year><volume>20</volume><fpage>657</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2285382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1445-5994.1990.tb00395.x</pub-id></element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Davila</surname><given-names>E</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>LB</given-names></name></person-group><article-title>Clinical value of the creatinine clearance before the administration of chemotherapy with cisplatin</article-title><source>Cancer</source><year>1987</year><volume>60</volume><fpage>161</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3594352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19870715)60:2&lt;161::aid-cncr2820600206&gt;3.0.co;2-v</pub-id></element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>McDermott</surname><given-names>DF</given-names></name><name name-style="western"><surname>Galindo</surname><given-names>A</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>RL</given-names></name><name name-style="western"><surname>Jaffe</surname><given-names>EA</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M</given-names></name><name name-style="western"><surname>Pasmantier</surname><given-names>MW</given-names></name></person-group><article-title>Inadequacy of predicted creatinine clearance as guide to chemotherapy</article-title><source>Cancer Treat Rep</source><year>1987</year><volume>71</volume><fpage>1067</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3677111</pub-id></element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Levey</surname><given-names>AS</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>JP</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>JB</given-names></name><name name-style="western"><surname>Greene</surname><given-names>T</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>N</given-names></name><name name-style="western"><surname>Roth</surname><given-names>D</given-names></name></person-group><article-title>A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group</article-title><source>Ann Intern Med</source><year>1999</year><volume>130</volume><fpage>461</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10075613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-130-6-199903160-00002</pub-id></element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Par&#305;ldar</surname><given-names>Z</given-names></name><name name-style="western"><surname>G&#252;lter</surname><given-names>C</given-names></name><name name-style="western"><surname>Habif</surname><given-names>S</given-names></name><name name-style="western"><surname>Mutaf</surname><given-names>I</given-names></name><name name-style="western"><surname>Turgan</surname><given-names>N</given-names></name><name name-style="western"><surname>&#214;zmen</surname><given-names>D</given-names></name><etal/></person-group><article-title>Age and gender associated changes in cystatin C and 2microglobulin</article-title><source>Turk J Med Sci</source><year>2002</year><volume>32</volume><fpage>317</fpage><lpage>21</lpage></element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsushima</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsukamoto</surname><given-names>E</given-names></name><name name-style="western"><surname>Tamaki</surname><given-names>N</given-names></name></person-group><article-title>Reappraisal of single-sample and gamma camera methods for determination of the glomerular filtration rate with <sup>99m</sup>Tc-DTPA</article-title><source>Ann Nucl Med</source><year>2000</year><volume>14</volume><fpage>143</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">10921477</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02987852</pub-id></element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>CD</given-names></name><name name-style="western"><surname>Bischoff</surname><given-names>PG</given-names></name><name name-style="western"><surname>Kontzen</surname><given-names>FN</given-names></name><name name-style="western"><surname>Rowell</surname><given-names>KL</given-names></name><name name-style="western"><surname>Yester</surname><given-names>MV</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Measurement of glomerular filtration rate: Single injection plasma clearance method without urine collection</article-title><source>J Nucl Med</source><year>1985</year><volume>26</volume><fpage>1243</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3903074</pub-id></element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Gates</surname><given-names>GF</given-names></name></person-group><article-title>Glomerular filtration rate: Estimation from fractional renal accumulation of <sup>99m</sup>Tc-DTPA (stannous)</article-title><source>AJR Am J Roentgenol</source><year>1982</year><volume>138</volume><fpage>565</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">7039273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2214/ajr.138.3.565</pub-id></element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Mantri</surname><given-names>R</given-names></name><name name-style="western"><surname>Kosana</surname><given-names>P</given-names></name><name name-style="western"><surname>Rallapeta</surname><given-names>RP</given-names></name><name name-style="western"><surname>Parthasaradhi</surname><given-names>R</given-names></name><name name-style="western"><surname>Aka</surname><given-names>S</given-names></name><name name-style="western"><surname>Kalawat</surname><given-names>T</given-names></name><etal/></person-group><article-title>Comparison of automatic correction versus manual depth correction in the calculation of glomerular filtration rates in gates renal processing of diethylenetriaminepenatacetic acid renogram in prospective renal donors</article-title><source>Indian J Transplant</source><year>2019</year><volume>13</volume><fpage>259</fpage><lpage>63</lpage></element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="book" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Mettler</surname><given-names>FA</given-names></name><name name-style="western"><surname>Milton</surname><given-names>JR</given-names></name><name name-style="western"><surname>Guiberteau</surname><given-names>J</given-names></name></person-group><article-title>Genitourinary system and adrenal glands</article-title><source>Essentials of Nuclear Medicine Imaging</source><edition>6th</edition><publisher-name>United States of America, Philadelphia</publisher-name><publisher-loc>Elsevier</publisher-loc><year>2012</year><fpage>315</fpage><lpage>44</lpage></element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Mandell</surname><given-names>GA</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>JA</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>JC</given-names></name><name name-style="western"><surname>Majd</surname><given-names>M</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JH</given-names></name><name name-style="western"><surname>Parisi</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Procedure guideline for diuretic renography in children. Society of Nuclear Medicine</article-title><source>J Nucl Med</source><year>1997</year><volume>38</volume><fpage>1647</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">9379208</pub-id></element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>A</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>C</given-names></name><name name-style="western"><surname>Giacometti</surname><given-names>A</given-names></name><name name-style="western"><surname>Hall</surname><given-names>EC</given-names></name><name name-style="western"><surname>Barefield</surname><given-names>KP</given-names></name></person-group><article-title>Improved formulas for the estimation of renal depth in adults</article-title><source>J Nucl Med</source><year>1993</year><volume>34</volume><fpage>1766</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8410296</pub-id></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>A</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Renal depth measured by CT optimize the glomerular filtration rate using the Gates method in living donor kidney transplantation</article-title><source>Chin J Organ Transplant</source><year>2019</year><volume>12</volume><fpage>195</fpage><lpage>9</lpage></element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>J</given-names></name><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ding</surname><given-names>X</given-names></name><etal/></person-group><article-title>Establishing a new formula for estimating renal depth in a Chinese adult population</article-title><source>Medicine (Baltimore)</source><year>2017</year><volume>96</volume><fpage>e5940</fpage><pub-id pub-id-type="pmid">28151880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000005940</pub-id><pub-id pub-id-type="pmcid">PMC5293443</pub-id></element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Granerus</surname><given-names>G</given-names></name><name name-style="western"><surname>Moonen</surname><given-names>M</given-names></name></person-group><article-title>Effects of extra-renal background subtraction and kidney depth correction in the measurement of GFR by gamma camera renography</article-title><source>Nucl Med Commun</source><year>1991</year><volume>12</volume><fpage>519</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">1866105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006231-199106000-00006</pub-id></element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Cosgriff</surname><given-names>P</given-names></name><name name-style="western"><surname>Brown</surname><given-names>H</given-names></name></person-group><article-title>Influence of kidney depth on the renographic estimation of relative renal function</article-title><source>J Nucl Med</source><year>1990</year><volume>31</volume><fpage>1576</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2395028</pub-id></element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>G</given-names></name><name name-style="western"><surname>Shao</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Establish new formulas for the calculation of renal depth in both children and adults</article-title><source>Clin Nucl Med</source><year>2015</year><volume>40</volume><fpage>e357</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">26018708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/RLU.0000000000000808</pub-id></element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Sugawara</surname><given-names>S</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>S</given-names></name><name name-style="western"><surname>Kojima</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ito</surname><given-names>H</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Oriuchi</surname><given-names>N</given-names></name></person-group><article-title>Feasibility of gamma camera-based GFR measurement using renal depth evaluated by lateral scan of (99m) Tc-DTPA renography</article-title><source>Ann Nucl Med</source><year>2020</year><volume>34</volume><fpage>349</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">32166712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12149-020-01455-w</pub-id></element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author"><name name-style="western"><surname>Hephzibah</surname><given-names>J</given-names></name><name name-style="western"><surname>Shanthly</surname><given-names>N</given-names></name><name name-style="western"><surname>Oommen</surname><given-names>R</given-names></name></person-group><article-title>Comparison of glomerular filtration rate measured by plasma sample technique, Cockroft Gault method and Gates&#8217; method in voluntary kidney donors and renal transplant recipients</article-title><source>Indian J Nucl Med</source><year>2013</year><volume>28</volume><fpage>144</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">24250022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0972-3919.119544</pub-id><pub-id pub-id-type="pmcid">PMC3822413</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>